EUVIMEDEUVIMED entdecken
Open Access

MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data

Jun-Ichi Satoh, Yoshihiro Kino, Shumpei Niida

Biomarker Insights · 2015-01 · 10 · BMI.S25132

DOI: 10.4137/bmi.s25132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomarker Insights, online erschienen am 15.04.2015. Verfasst von Jun-Ichi Satoh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, Tokyo, Japan. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is the most common cause of dementia with no curative therapy currently available. Establishment of sensitive and non-invasive biomarkers that promote an early diagnosis of AD is crucial for the effective administration of disease-modifying drugs. MicroRNAs (miRNAs) mediate posttranscriptional repression of numerous target genes. Aberrant regulation of miRNA expression is implicated in AD pathogenesis, and circulating miRNAs serve as potential biomarkers for AD. However, data analysis of numerous AD-specific miRNAs derived from small RNA-sequencing (RNA-Seq) is most often laborious.

Methods

To identify circulating miRNA biomarkers for AD, we reanalyzed a publicly available small RNA-Seq dataset, composed of blood samples derived from 48 AD patients and 22 normal control (NC) subjects, by a simple web-based miRNA data analysis pipeline that combines omiRas and DIANA miRPath.

Results

By using omiRas, we identified 27 miRNAs expressed differentially between both groups, including upregulation in AD of miR-26b-3p, miR-28–3p, miR-30c-5p, miR-30d-5p, miR-148b-5p, miR-151a-3p, miR-186–5p, miR-425–5p, miR-550a-5p, miR-1468, miR-4781–3p, miR-5001–3p, and miR-6513–3p and downregulation in AD of let-7a-5p, let-7e-5p, let-7f-5p, let-7g-5p, miR-15a-5p, miR-17–3p, miR-29b-3p, miR-98–5p, miR-144–5p, miR-148a-3p, miR-502–3p, miR-660–5p, miR-1294, and miR-3200–3p. DIANA miRPath indicated that miRNA-regulated pathways potentially down– regulated in AD are linked with neuronal synaptic functions, while those upregulated in AD are implicated in cell survival and cellular communication.

Conclusions

The simple web-based miRNA data analysis pipeline helps us to effortlessly identify candidates for miRNA biomarkers and pathways of AD from the complex small RNA–Seq data.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseDIANA miRPathbiomarkersdata analysis pipelinemicroRNAomiRassmall RNA-Seq

Autor:innen und Institutionen

  • Department of Bioinformatics and Molecular Neuropathology, Meiji Pharmaceutical University, Tokyo, Japan.
  • BioBank Omics Unit, National Center for Geriatrics and Gerontology (NCGG), bu, Aichi, Japan.

Zitieren

APA

Satoh, J., Kino, Y., & Niida, S. (2015). MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data. Biomarker Insights, 10, BMI.S25132. https://doi.org/10.4137/bmi.s25132

Vancouver

Satoh J, Kino Y, Niida S. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data. Biomarker Insights. 2015;10:BMI.S25132. doi:10.4137/bmi.s25132

BibTeX
@article{Satoh2015,
  author = {Satoh, Jun-Ichi and Kino, Yoshihiro and Niida, Shumpei},
  title = {MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data},
  journal = {Biomarker Insights},
  year = {2015},
  volume = {10},
  pages = {BMI.S25132},
  doi = {10.4137/bmi.s25132}
}
Kostenlos starten →